Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care

Similar documents
2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Measure #279: Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy National Quality Strategy Domain: Effective Clinical Care

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Quality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Quality ID #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care

Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Measure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care

Quality ID #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

DENOMINATOR: All patients aged 18 years and older seen for at least two visits or at least one preventive visit during the measurement period

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

Measure #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Measure #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Definition: Active injection drug users - Those who have injected any drug(s) within the 12 month reporting period

Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

DESCRIPTION: Percentage of patients aged 5 years and older with a diagnosis of persistent asthma who were prescribed long-term control medication

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care

DESCRIPTION: Percentage of new patients whose biopsy results have been reviewed and communicated to the primary care/referring physician and patient

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40%

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care

Measure #76: Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections National Quality Strategy Domain: Patient Safety

Quality ID #76: Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections National Quality Strategy Domain: Patient Safety

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

DESCRIPTION: Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months

Measure #286: Dementia: Counseling Regarding Safety Concerns National Quality Strategy Domain: Patient Safety

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Measure #72 (NQF 0385): Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients National Quality Strategy Domain: Effective Clinical Care

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

DENOMINATOR: All patient visits for patients aged 21 years and older with a diagnosis of OA

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Denominator Criteria (Eligible Cases): Patient encounter during the performance period (CPT): 78300, 78305, 78306, 78315, 78320

Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes

Quality ID #39 (NQF 0046): Screening for Osteoporosis for Women Aged Years of Age National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

NUMERATOR: Patients who had baseline cytogenetic testing performed on bone marrow

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #156 (NQF 0382): Oncology: Radiation Dose Limits to Normal Tissues National Quality Strategy Domain: Patient Safety

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #224 (NQF 0562): Melanoma: Overutilization of Imaging Studies in Melanoma National Quality Strategy Domain: Efficiency and Cost Reduction

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Measure #156 (NQF 0382): Oncology: Radiation Dose Limits to Normal Tissues National Quality Strategy Domain: Patient Safety

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

Quality ID #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process-High Priority

DENOMINATOR: All patients 18 and older prescribed opiates for longer than six weeks duration

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

DENOMINATOR: All female patients aged 65 years and older with a diagnosis of urinary incontinence

Measure #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination

Quality ID #414: Evaluation or Interview for Risk of Opioid Misuse National Quality Strategy Domain: Effective Clinical Care

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

Quality ID #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety

DENOMINATOR: All patients, regardless of age, with a diagnosis of inflammatory bowel disease who initiated an anti-tnf agent

Transcription:

Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage of patients aged 18 years and older with a diagnosis of moderate or severe obstructive sleep apnea who were prescribed positive airway pressure therapy INSTRUCTIONS: This measure is to be submitted a minimum of once per performance period for patients with a diagnosis of sleep apnea seen during the performance period. This measure may be submitted by eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding. Measure Submission: The listed denominator criteria is used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions allowed by the measure. The quality-data codes listed do not need to be submitted for registry-based submissions; however, these codes may be submitted for those registries that utilize claims data. DENOMINATOR: All patients aged 18 years and older with a diagnosis of sleep apnea Denominator Criteria (Eligible Cases): Patients aged 18 years on date of encounter AND Diagnosis for sleep apnea (ICD-10-CM): G47.30, G47.33 AND Patient encounter during the performance period (CPT): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350 WITHOUT Telehealth Modifier: GQ, GT, 95, POS 02 AND Moderate or severe obstructive sleep apnea (apnea hypopnea index (AHI) or respiratory disturbance index (RDI) of 15 or greater): G8846 NUMERATOR: Patients who were prescribed positive airway pressure therapy Definition: Moderate or severe sleep apnea - apnea hypopnea index (AHI) or a respiratory disturbance index (RDI) greater than or equal to 15 episodes per hour of sleep OR Numerator Options: Performance Met: Positive airway pressure therapy prescribed (G8845) Page 1 of 6

OR Denominator Exception: Performance t Met: Documentation of reason(s) for not prescribing positive airway pressure therapy (e.g., patient unable to tolerate, alternative therapies used, patient declined, financial, insurance coverage) (G8849) Positive airway pressure therapy not prescribed, reason not given (G8850) RATIONALE: All patients with moderate to severe obstructive sleep apnea (OSA) should have an initial trial of nasal continuous positive air pressure (CPAP); Level 1 evidence also recommends that patients with severe OSA should have an initial trial of nasal CPAP because greater effectiveness has been shown with this intervention than with the use of other treatments (Kushida et al, 2006). Level 1 studies also show that CPAP eliminates respiratory disturbances, reducing the apnea hypopnea index (AHI). All of the 11 clinical trials that studied this outcome demonstrated that CPAP was superior to placebo, conservative management, and positional therapy. This effect was demonstrated during follow-up polysomnography (Gay et al, 2006). Treatment with CPAP must be based on a prior diagnosis of OSA established using an acceptable method of diagnosis. CLINICAL RECOMMENDATION STATEMENTS: CPAP is indicated for the treatment of moderate to severe OSA (Level 1). CPAP is recommended for the treatment of mild OSA (Level 2). CPAP is indicated for improving self-reported sleepiness in patients with OSA (Level 1). This recommendation is based on 10 randomized controlled trials in which CPAP reduced sleepiness more than control procedures in patients with OSA. CPAP is recommended for improving quality of life in patients with OSA. (Kushida et al, 2006) (Level 1 and Level 2 studies) COPYRIGHT: The Measures are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the American Medical Association (AMA), [on behalf of the Physician Consortium for Performance Improvement (PCPI )] or American Academy of Sleep Medicine (AASM). Neither the AMA, AASM, PCPI, nor its members shall be responsible for any use of the Measures. The AMA s, PCPI s and National Committee for Quality Assurance s significant past efforts and contributions to the development and updating of the Measures is acknowledged. AASM is solely responsible for the review and enhancement ( Maintenance ) of the Measures as of August 7, 2014. AASM encourages use of the Measures by other health care professionals, where appropriate. THE MEASURES AND SPECIFICATIONS ARE PROVIDED AS IS WITHOUT WARRANTY OF ANY KIND. 2016 American Medical Association and American Academy of Sleep Medicine. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use. Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, AASM, the PCPI and its Page 2 of 6

members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT ) or other coding contained in the specifications. CPT contained in the Measures specifications is copyright 2004-2017 American Medical Association. LOINC copyright 2004-2017 Regenstrief Institute, Inc. SNOMED CLINICAL TERMS (SNOMED CT ) copyright 2004-2017 College of American Pathologists. All Rights Reserved. Page 3 of 6

2018 Registry Flow for Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed Denominator Start Numerator Patient Age at Date of Encounter 18 Years Positive Airway Pressure Therapy Prescribed Data Completeness Met + Performance Met G8845 or equivalent (50 patients) a t Included in Eligible Population/Denominator Diagnosis of Sleep Apnea as Listed in Denominator* Encounter Codes as Listed in Denominator* (1/1/2018 thru 12/31/2018) Documentation of Reason for t Prescribing Positive Airway Pressure Therapy (e.g. Patient Unable to Tolerate, Alternative Therapies Used, Patient Declined, Financial, Insurance Coverage) Data Completeness Met + Denominator Exception G8849 or equivalent (10 patients) b Telehealth Modifier: GQ, GT, 95, POS 02 Positive Airway Pressure Therapy, t Prescribed, Reason t Given Data Completeness Met + Performance t Met G8850 or equivalent (10 patients) c Include in Eligible Population/ Denominator (80 patients) d Moderate to Severe Obstructive Sleep Apnea (Apnea Hypopnea Index (AHI) or Respiratory Disturbance Index (RDI) of 15 or Greater) G8846 or equivalent Data Completeness t Met Quality-Data Code or equivalent not submitted (10 patients) SAMPLE CALCULATIONS: Data Completeness= Performance Met (a=50 patients) + Denominator Exception (b=10 patients) + Performance t Met (c=10 patients) = 70 patients = 87.50% Eligible Population / Denominator (d=80 patients) = 80 patients Performance Rate= Performance Met (a=50 patients) = 50 patients = 83.33% Data Completeness Numerator (70 patients) Denominator Exception (b=10 patients) = 60 patients * See the posted Measure Specification for specific coding and instructions to submit this measure. NOTE: Submission Frequency: Patient-process CPT only copyright 2017 American Medical Association. All All rights reserved. The measure diagrams were developed by by CMS as as a supplemental resource to to be be used in in conjunction with the measure specifications. They should not be be used alone or or as as a substitution for the measure specification. v2 v2 Page 4 of 6

2018 Registry Flow For Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed Please refer to the specific section of the specification to identify the denominator and numerator information for use in submitting this Individual Specification. This flow is for registry data submission. 1. Start with Denominator 2. Check Patient Age: a. If the Age is greater than or equal to 18 years of age on Date of Service and equals during the measurement period, do not include in Eligible Patient Population. Stop Processing. b. If the Age is greater than or equal to 18 years of age on Date of Service and equals during the measurement period, proceed to check Patient Diagnosis. 3. Check Patient Diagnosis: a. If Diagnosis of Sleep Apnea as Listed in the Denominator equals, do not include in Eligible Patient Population. Stop Processing. b. If Diagnosis of Sleep Apnea as Listed in the Denominator equals, proceed to check Current Encounter Performed. 4. Check Encounter Performed: a. If Encounter as Listed in the Denominator equals, do not include in Eligible Patient Population. Stop Processing. b. If Encounter as Listed in the Denominator equals, proceed to check Telehealth Modifier. 5. Check Telehealth Modifier: a. If Telehealth Modifier equals, do not include in Eligible Patient Population. Stop Processing. b. If Telehealth Modifier equals, proceed to check Moderate to Severe Obstructive Sleep Apnea (Apnea Hypopnea Index (AHI) or Respiratory Disturbance Index (RDI) of 15 or Greater). 6. Check Moderate to Severe Obstructive Sleep Apnea (Apnea Hypopnea Index (AHI) or Respiratory Disturbance Index (RDI) of 15 or Greater): a. If Moderate to Severe Obstructive Sleep Apnea (Apnea Hypopnea Index (AHI) or Respiratory Disturbance Index (RDI) of 15 or Greater) include in Eligible Population equals, do not include in Eligible Patient Population. Stop Processing. b. If Moderate to Severe Obstructive Sleep Apnea (Apnea Hypopnea Index (AHI) or Respiratory Disturbance Index (RDI) of 15 or Greater) equals, include in Eligible Population. 7. Denominator Population: a. Denominator population is all Eligible Patients in the denominator. Denominator is represented as Denominator in the Sample Calculation listed at the end of this document. Letter d equals 80 patients in the Sample Calculation. 8. Start Numerator Page 5 of 6

9. Check Positive Airway Pressure Therapy Prescribed: a. If Positive Airway Pressure Therapy Prescribed equals, include in Data Completeness Met and Performance Met. b. Data Completeness Met and Performance Met is represented in the Data Completeness and Performance Rate in the Sample Calculation listed at the end of this document. Letter a equals 50 patients in Sample Calculation. c. If Positive Airway Pressure Therapy Prescribed equals, proceed to Documentation of Reason for t Prescribing Positive Airway Pressure Therapy (e.g. Patient Unable to Tolerate, Alternative Therapies Used, Patient Declined, Financial, Insurance Coverage). 10. Check Documentation of Reason for t Prescribing Positive Airway Pressure Therapy (e.g. Patient Unable to Tolerate, Alternative Therapies Used, Patient Declined, Financial, Insurance Coverage): a. If Documentation of Reason for t Prescribing Positive Airway Pressure Therapy (e.g. Patient Unable to Tolerate, Alternative Therapies Used, Patient Declined, Financial, Insurance Coverage) equals, include in Data Completeness Met and Denominator Exception. b. Data Completeness Met and Denominator Exception is represented in the Data Completeness and Performance Rate in the Sample Calculation listed at the end of this document. Letter b equals 10 patients in Sample Calculation. c. If Documentation of Reason for t Prescribing Positive Airway Pressure Therapy (e.g. Patient Unable to Tolerate, Alternative Therapies Used, Patient Declined, Financial, Insurance Coverage) equals, proceed to Positive Airway Pressure Therapy, t Prescribed, Reason t Given. 11. Check Positive Airway Pressure Therapy, t Prescribed, Reason t Given: a. If Positive Airway Pressure Therapy, t Prescribed, Reason t Given equals, include in Data Completeness Met and Performance t Met. b. Data Completeness Met and Performance t Met is represented in the Data Completeness in the Sample Calculation listed at the end of this document. Letter c equals 10 patients in the Sample Calculation. c. If Positive Airway Pressure Therapy, t Prescribed, Reason t Given equals, proceed to Data Completeness t Met. 12. Check Data Completeness t Met: a. If Data Completeness t Met equals, Quality Data Code or equivalent not submitted. 10 patients have been subtracted from the Data Completeness Numerator in the Sample Calculation. SAMPLE CALCULATIONS: Data Completeness= Performance Met (a=50 patients) + Denominator Exception (b=10 patients) + Performance t Met (c=10 patients) = 70 patients = 87.50% Eligible Population / Denominator (d=80 patients) = 80 patients Performance Rate= Performance Met (a=50 patients) = 50 patients = 83.33% Data Completeness Numerator (70 patients) Denominator Exception (b=10 patients) = 60 patients Page 6 of 6